Biotechnology Frontiers

Tuesday, October 03, 2006

Todays Biotechnology News

  • Generex Biotechnology Corporation (NASDAQ: GNBT)announced today publication of studies demonstrating specific anti-tumoractivity of its novel Ii-Key/HER-2/neu immunotherapeutic vaccine. Thestudies were performed in the laboratory of Dr. Costas Baxevanis incollaboration with scientists at Antigen Express, the immunotherapeuticdivision of Generex Biotechnology.
  • InNexus Biotechnology (TSX VENTURE:IXS) (OTCBB:IXSBF) today announced that it has entered into a technology collaboration agreement to evaluate the use of InNexus' SuperAntibody Technology in combination with an antibody for the treatment of certain viral infections.
  • ImClone Systems Inc. on Tuesday urged shareholders to reject a call by billionaire investor Carl Icahn to dislodge six of the biotechnology company's board members and elect an Icahn nominee.


Post a Comment

<< Home